New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1726+0.0011 (+0.64%)
At close: 04:00PM EST
0.1800 +0.01 (+4.29%)
Pre-market: 04:05AM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
881.705
3,937
36,144
Operating expenses
Research development
15,658
36,445
98,267
89,605
Selling general and administrative
18,379
20,425
28,480
23,643
Total operating expenses
34,037
56,871
126,747
113,248
Operating income or loss
-34,037
-55,989
-122,810
-77,105
Total other income/expenses net
-5,810
12,179
12,569
4,423
Income before tax
-41,729
-45,640
-111,269
-71,454
Income from continuing operations
-41,729
-45,640
-111,269
-71,454
Net income
-41,729
-45,640
-111,269
-71,454
Net income available to common shareholders
-41,729
-45,640
-111,269
-71,454
Basic EPS
-
-0.37
-1.42
-1.12
Diluted EPS
-
-0.37
-1.42
-1.12
Basic average shares
-
122,990
78,133
63,899
Diluted average shares
-
122,990
78,133
63,899
EBITDA
-
-54,350
-121,116
-75,875